The CRC Blueprint

My scientific approach to my own cancer – shared with you.

Recruiting now

MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

Phase 1 · randomised · 630 people · 52 sites in 9 countries · Recruiting now

August 8, 2026
Single Arm Study of Neoadjuvant Dostarlimab in Stage II and III Deficient Mismatch Repair Colon Cancers

Phase 2 · 25 people · 2 sites in United States · Recruiting now

August 8, 2026
Open-label Phase 2 Study of Avutometinib (RAF/MEK Clamp) in Combination With Defactinib (FAK Inhibitor) and Cetuximab in Patients With Unresectable, Anti-EGFR-Refractory Advanced Colorectal Cancer

Phase 2 · 33 people · 1 site in United States · Recruiting now

August 8, 2026
Tumor Local Excision +Postoperative Adjuvant Chemoradiotherapy for T1-2N0M0 Low/Ultra-Low Rectal Cancer

Phase 2 · 60 people · 1 site in China · Recruiting now

August 8, 2026
Safety of Mid and Low Rectal Cancer Surgery Without Dissection of the No.253 Lymph Node

Not phased · randomised · 1,384 people · 8 sites in China · Recruiting now

August 8, 2026
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

Phase 2 · randomised · 285 people · 6 sites in United States · Recruiting now

August 8, 2026
CAPOX and PD-1 Antibody Combined With or Without Radiotherapy for MSS Locally Advanced Rectal Cancer

Phase 2 · randomised · 192 people · 1 site in China · Recruiting now

August 8, 2026
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer

Phase 2 · 332 people · 1 site in United States · Recruiting now

August 8, 2026
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Phase 1 · randomised · 1,394 people · 122 sites in 13 countries · Recruiting now

August 8, 2026
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

Phase 2 · 1,130 people · 32 sites in United States · Recruiting now

August 8, 2026